Cargando…

Combination of Tumor Mutational Burden and Specific Gene Mutations Stratifies Outcome to Immunotherapy Across Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma

Purpose: To investigate the prognostic significance of tumor mutational burden (TMB) combined with specific prognosis-related gene mutations in immunotherapy for recurrent and metastatic head and neck squamous cell carcinoma (r/m HNSCC). Methods: One hundred thirty-two r/m HNSCC patients from the Mo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Ying-Peng, Wang, Rong, Liu, Qiao-Dan, Xu, Xi-Wei, Wei, Wei, Huang, Xiao-Tao, Peng, Xiao-Mou, Liu, Zhi-Gang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637214/ https://www.ncbi.nlm.nih.gov/pubmed/34868231 http://dx.doi.org/10.3389/fgene.2021.756506

Ejemplares similares

Age and Mutations as Predictors of the Response to Immunotherapy in Head and Neck Squamous Cell Cancer
por: Zhang, Yueming, et al.
Publicado: (2020)

Systematic Profiling of Immune Risk Model to Predict Survival and Immunotherapy Response in Head and Neck Squamous Cell Carcinoma
por: Liu, Xingyu, et al.
Publicado: (2020)

TMED2/9/10 Serve as Biomarkers for Poor Prognosis in Head and Neck Squamous Carcinoma
por: Gao, Wen, et al.
Publicado: (2022)

Genomic Landscape of Head and Neck Squamous Cell Carcinoma Across Different Anatomic Sites in Chinese Population
por: Ju, Yunhe, et al.
Publicado: (2021)

Immunogenomic alterations of head and neck squamous cell carcinomas stratified by smoking status
por: Huang, Yixuan, et al.
Publicado: (2021)

Integrated Analysis of RNA-Binding Proteins Associated With the Prognosis and Immunosuppression in Squamous Cell Carcinoma of Head and Neck
por: Hu, Guangsheng, et al.
Publicado: (2021)

Mutational landscape of head and neck squamous cell carcinomas in a South Asian population
por: Ghias, Kulsoom, et al.
Publicado: (2019)

Identification and validation of a prognostic model based on ferroptosis-associated genes in head and neck squamous cancer
por: Wei, Ming, et al.
Publicado: (2022)

Immunotherapy in Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck
por: Hsieh, Ronan W., et al.
Publicado: (2021)

Mutation Frequency in Main Susceptibility Genes Among Patients With Head and Neck Paragangliomas
por: Snezhkina, Anastasiya V., et al.
Publicado: (2020)

Poor prognosis, hypomethylation, and immune infiltrates are associated with downregulation of INMT in head and neck squamous cell carcinoma
por: Cui, Kun, et al.
Publicado: (2022)

Systemic Analysis on the Features of Immune Microenvironment Related to Prognostic Signature in Head and Neck Squamous Cell Carcinoma
por: Su, Kaixin, et al.
Publicado: (2022)

Tumor Mutational Burden as a Predictor of Survival with Durvalumab and/or Tremelimumab Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Wildsmith, Sophie, et al.
Publicado: (2023)

The role of the genomic mutation signature and tumor mutation burden on relapse risk prediction in head and neck squamous cell carcinoma after concurrent chemoradiotherapy
por: Wang, Hui-Ching, et al.
Publicado: (2023)

Prognostic biomarker GSTK1 in head and neck squamous cell carcinoma and its correlation with immune infiltration and DNA methylation
por: Feng, Yao, et al.
Publicado: (2023)

A Ferroptosis-Related Prognostic Signature Based on Antitumor Immunity and Tumor Protein p53 Mutation Exploration for Guiding Treatment in Patients With Head and Neck Squamous Cell Carcinoma
por: Fan, Xin, et al.
Publicado: (2021)

A Glycosyltransferase-Related Signature for Predicting Overall Survival in Head and Neck Squamous Cell Carcinoma
por: Wu, Huili, et al.
Publicado: (2022)

A novel anoikis-related gene signature predicts prognosis in patients with head and neck squamous cell carcinoma and reveals immune infiltration
por: Chi, Hao, et al.
Publicado: (2022)

A novel immune signature predicts immunotherapy responsiveness and reveals the landscape of the tumor immune microenvironment in head and neck squamous cell carcinoma
por: Wang, Qiwei, et al.
Publicado: (2022)

A Ferroptosis-Related Gene Signature for Predicting the Prognosis and Drug Sensitivity of Head and Neck Squamous Cell Carcinoma
por: Lu, Wei, et al.
Publicado: (2021)

Developing a pyroptosis-related gene signature to better predict the prognosis and immune status of patients with head and neck squamous cell carcinoma
por: Liu, Dan, et al.
Publicado: (2023)

Integrative Analysis of TP53INP2 in Head and Neck Squamous Cell Carcinoma
por: Cao, Ruoyan, et al.
Publicado: (2021)

Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma
por: Sanati, Nasim, et al.
Publicado: (2018)

Epigenetic Regulations of Perineural Invasion in Head and Neck Squamous Cell Carcinoma
por: Hurník, Pavel, et al.
Publicado: (2022)

Prediction of Radiosensitivity in Head and Neck Squamous Cell Carcinoma Based on Multiple Omics Data
por: Liu, Jie, et al.
Publicado: (2020)

Immunotherapy Breakthroughs in the Treatment of Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
por: Borel, Christian, et al.
Publicado: (2020)

PBRM1 mutation as a predictive biomarker for immunotherapy in multiple cancers
por: Dai, Jiali, et al.
Publicado: (2023)

The prognostic value and immune landscape of a cuproptosis-related lncRNA signature in head and neck squamous cell carcinoma
por: Li, Yao jun, et al.
Publicado: (2022)

Association of RYR2 Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma
por: Liu, Zaoqu, et al.
Publicado: (2021)

EGFR Mutations in Head and Neck Squamous Cell Carcinoma
por: Nair, Sindhu, et al.
Publicado: (2022)

Nine-gene signature and nomogram for predicting survival in patients with head and neck squamous cell carcinoma
por: Yang, Fan, et al.
Publicado: (2022)

Identification of a Prognostic Model Based on Fatty Acid Metabolism-Related Genes of Head and Neck Squamous Cell Carcinoma
por: Du, Peiyu, et al.
Publicado: (2022)

Induction chemotherapy combined with immunotherapy in locally advanced head and neck squamous cell carcinoma
por: Li, Xia, et al.
Publicado: (2021)

Can a genetic signature for metastatic head and neck squamous cell carcinoma be characterised by comparative genomic hybridisation?
por: Patmore, H S, et al.
Publicado: (2004)

USH2A Mutation is Associated With Tumor Mutation Burden and Antitumor Immunity in Patients With Colon Adenocarcinoma
por: Sun, Yuanyuan, et al.
Publicado: (2021)

In Reply: TP53 Alteration Status and Tumor Mutational Burden Score: Prevalence and Prognosis in Head and Neck Squamous Cell Carcinoma
por: Burcher, Kimberly M, et al.
Publicado: (2022)

An original cuproptosis-related genes signature effectively influences the prognosis and immune status of head and neck squamous cell carcinoma
por: Zheng, Xiwang, et al.
Publicado: (2023)

Cuproptosis-Related lncRNAs are Biomarkers of Prognosis and Immune Microenvironment in Head and Neck Squamous Cell Carcinoma
por: Yang, Liuqing, et al.
Publicado: (2022)

Current status and perspective of tumor immunotherapy for head and neck squamous cell carcinoma
por: Yu, Chenhang, et al.
Publicado: (2022)

Immunotherapy for head and neck squamous cell carcinoma
por: Fuereder, Thorsten
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_stub5o1un4kjp4rrivvrml5ibb